Population Pharmacokinetics of Caffeine in Infants with Hypoxic‐Ischemic Encephalopathy: A Phase I, Dose‐Escalating Trial
Elizabeth J. Thompson(University of North Carolina at Chapel Hill), Wesley Jackson(University of North Carolina at Chapel Hill), Matthew M. Laughon(University of North Carolina at Chapel Hill), Julie B. Dumond(University of North Carolina at Chapel Hill), Daniel González(University of North Carolina at Chapel Hill), Christoph P. Hornik(Duke University), Alison Kilborn(Clinical Research Institute)
Cited by 6
Related Papers
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
|American Journal of Respiratory and Critical Care Medicine|2019|1.2k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232